Defining the clinical phenotype of COVID-19 in children.

Content Provider	Europe PMC
Author	Giacomet, Vania Stracuzzi, Marta Paradiso, Laura Di Cosimo, Maria Elisabetta Rubinacci, Valeria Zuccotti, GianVincenzo
Abstract	AbstractOn January 7, 2020, a novel coronavirus (SARS‐CoV‐2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS‐CoV‐2 discovery, the corresponding disease (COVID‐19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID‐19 had been confirmed worldwide, with more than 318.599 deaths.
Related Links	https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7753524&blobtype=pdf
Page Count	3
ISSN	09056157
Journal	Pediatric Allergy and Immunology [Pediatr Allergy Immunol]
Volume Number	31 Suppl 26
DOI	10.1111/pai.13355
PubMed Central reference number	PMC7753524
Issue Number	Suppl 26
PubMed reference number	33236440
e-ISSN	13993038
Language	English
Publisher	John Wiley and Sons Inc.
Publisher Date	2020-11-01
Publisher Place	Hoboken
Access Restriction	Open
Rights License	This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. © 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Subject Keyword	children COVID‐19 Italy SARS‐CoV‐2
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology Pediatrics, Perinatology and Child Health